Hearing evaluation in COVID 19 recovered patients
Not Applicable
- Registration Number
- CTRI/2021/06/033943
- Lead Sponsor
- Yenepoya Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Subjects in the age group 18years to 50years who have recovered from COVID 19 infection who have either been treated or not with hydroxychloroquine
Exclusion Criteria
Age above 50 years
Middle ear disease
Individual who have past history of hearing loss
Diabetes mellitus
Genetic disorders of hearing
Congenital ear abnormalities
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of COVID 19 survivors with hearing loss. <br/ ><br>Degree of hearing loss in COVID 19 survivors with use of hydroxychloroquine or without use of hydroxychloroquine.Timepoint: 18 months
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI